Pharmaceutical

SK bioscience’s typhoid vaccine receives WHO prequalification

SK bioscience has achieved a significant milestone with its typhoid conjugate vaccine, SKYTyphoid, receiving WHO prequalification.

Feb 26, 2024 - 18:00
SK bioscience’s typhoid vaccine receives WHO prequalification
SK bioscience has achieved a significant milestone with its typhoid conjugate vaccine, SKYTyphoid, receiving WHO prequalification.
Read the original article

Tags:

Previous Article

Merck’s Keytruda regimen gains positive EMA CHMP opinion

Next Article

Moderna concludes construction at new mRNA vaccine facility in Canada

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Medical packaging companies in pharmaceutical contract manufacturing 

Medical packaging companies in pharmaceutical contract ...

Jun 26, 2024

STAT+: FDA approves Sage Therapeutics’ rapid-acting medication for postpartum depression but not major depression

STAT+: FDA approves Sage Therapeutics’ rapid-acting med...

Aug 5, 2023

Roche wins first-line approval for PI3K inhibitor combo in breast cancer

Roche wins first-line approval for PI3K inhibitor combo...

Oct 12, 2024